Forte BiosciencesFBRX
Market Cap: $10.2M
About: Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
Employees: 11
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
3% more funds holding
Funds holding: 32 [Q1] → 33 (+1) [Q2]
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
0.01% less ownership
Funds ownership: 52.33% [Q1] → 52.33% (-0.01%) [Q2]
23% less capital invested
Capital invested by funds: $13.3M [Q1] → $10.2M (-$3.04M) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Chardan Capital Daniil Gataulin 33% 1-year accuracy 6 / 18 met price target | 971%upside $75 | Buy Maintained | 19 Aug 2024 |